Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19 Lung Injury: A Systematic Review and Meta-Analysis.
Iran Biomed J
; 25(6): 381-9, 2021 11 01.
Article
en En
| MEDLINE
| ID: mdl-34641641
ABSTRACT
Background:
Lung injury is common in coronavirus disease 2019 (COVID-19) patients. The severity of lung injury appears to be reflected in serum Krebs von den Lungen-6 (KL-6), a glycoprotein expressed on type II alveolar epithelium. This study aims to assess the role of serum KL-6 in reflecting the severity of lung injury in COVID-19 patients.Methods:
A systematic search was conducted in Scopus, PubMed, Wiley Online Library, and ProQuest. Articles were screened based on several eligibility criteria and assessed for study quality using Newcastle-Ottawa Scale.Results:
This systematic review included four studies involving a total of 151 adult COVID-19 patients. Pooled analysis revealed that serum KL-6 was significantly higher in severe patients (SMD = 1.16; 95% CI = 0.691.63) with moderately high pooled sensitivity (79%; 95% CI = 6191%) and specificity (86%; 95% CI = 7295%).Conclusion:
High serum KL-6 may depict more severe lung injury in COVID-19 patients with moderately high sensitivity and specificity.Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Índice de Severidad de la Enfermedad
/
Mucina-1
/
Lesión Pulmonar
/
COVID-19
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Idioma:
En
Revista:
Iran Biomed J
Asunto de la revista:
BIOLOGIA
/
MEDICINA
Año:
2021
Tipo del documento:
Article